Back to search

Eastern Michigan University

An improved synthesis of the HDAC inhibitor trichostatin A

Abstract

dc:description.abstract

Histone deacetylase inhibitors (HDIs) have found a wide variety of medicinal uses and are most noted for their specific apoptotic action towards cancer cells. Several hydroxamate HDIs have since been moved on to phase 1 and 2 clinical drug trials, with one having already been approved for treatment of advanced cutaneous T-cell lymphoma. Trichostatin A is one of the most potent known naturally-occurring inhibitors of histone deacetylase. Unfortunately for researchers, the syntheses that have been reported are both long and difficult, which leads to a low overall yield and therefore to a prohibitively expensive product, limiting its medicinal potential. This work builds on several previously published syntheses and shows a more efficient synthesis of Trichostatin A, which will make it more available for use in a variety of treatments.

Degree

thesis:*
Name thesis:degree_name
Master of Science (MS)
Level thesis:degree_level
Open Access Thesis
Discipline thesis:degree_discipline
Chemistry

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Colombo, Joseph
Contributors dc:contributor
  • Andrei Kornilov, PhD
  • Harriet Lindsay, PhD
  • Cory Emal, PhD

Subjects

dc:subject × 3

Identifiers

dc:identifier.*
Repository record dc:identifier
https://commons.emich.edu/theses/237

Chain of custody

source
Harvested from
Eastern Michigan University
Base URL
commons.emich.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Colombo, Joseph. An improved synthesis of the HDAC inhibitor trichostatin A. Open Access Thesis thesis, https://commons.emich.edu/theses/237